Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
IACP Statement to Kaiser Health News Reporter
Share |

The International Academy of Compounding Pharmacists (IACP) does not condone marketing or billing practices involving Fraud, Waste or Abuse (FWA) as it pertains to billing for compounded medications. Legitimately prescribed and dispensed compounded medications can dramatically improve a patient’s quality of life or even save a patient’s life.


The prescriber is the best person to determine an appropriate treatment regimen for a patient; deference should be given to a prescriber's decisions regarding the best care for a prescriber's patient. Clearly, proper controls around the billing of compounded medications are needed to ensure patients can still access these important medications. It is apparent from the OIG report those proper controls are not in place. IACP is open to working both with public and private insurers to work towards a system which ensure patient access but protects the insurer from fraudulent practices. It is important to note – even at the increase rate of spending on compounding medications, the Part D spend on compounds is less than 0.4% of the total drug spend in 2015.

Association Management Software Powered by YourMembership  ::  Legal